Roche Holding AG (OTCMKTS:RHHBY) Receives Consensus Rating of “Hold” from Brokerages

Roche Holding AG (OTCMKTS:RHHBY) has received a consensus rating of “Hold” from the six analysts that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating on the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $40.00.

A number of analysts have commented on RHHBY shares. Morgan Stanley lowered shares of Roche from an “equal weight” rating to an “underweight” rating in a research note on Tuesday, January 16th. Argus restated a “hold” rating on shares of Roche in a research note on Monday, March 4th.

Roche Stock Performance

Shares of RHHBY stock opened at $30.33 on Thursday. The firm has a fifty day simple moving average of $31.87 and a two-hundred day simple moving average of $33.57. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.04 and a current ratio of 1.35. Roche has a 12 month low of $29.80 and a 12 month high of $40.48.

Institutional Trading of Roche

Institutional investors have recently made changes to their positions in the company. Saratoga Research & Investment Management boosted its holdings in shares of Roche by 6.9% in the 1st quarter. Saratoga Research & Investment Management now owns 2,458,918 shares of the company’s stock worth $78,489,000 after buying an additional 158,482 shares during the last quarter. Pacer Advisors Inc. boosted its holdings in shares of Roche by 1,937.5% in the 4th quarter. Pacer Advisors Inc. now owns 1,099,659 shares of the company’s stock worth $39,841,000 after buying an additional 1,045,687 shares during the last quarter. OLD National Bancorp IN boosted its holdings in shares of Roche by 2.0% in the 3rd quarter. OLD National Bancorp IN now owns 251,843 shares of the company’s stock worth $8,619,000 after buying an additional 4,956 shares during the last quarter. Hikari Power Ltd boosted its holdings in shares of Roche by 0.8% in the 4th quarter. Hikari Power Ltd now owns 237,820 shares of the company’s stock worth $8,616,000 after buying an additional 2,000 shares during the last quarter. Finally, Altrius Capital Management Inc boosted its holdings in shares of Roche by 2.9% in the 4th quarter. Altrius Capital Management Inc now owns 176,001 shares of the company’s stock worth $6,377,000 after buying an additional 4,939 shares during the last quarter.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.